Umecrine Cognition

Solna, Sweden · Founded 2006 · Privately Held (backing)

Developer of pharmaceutical drugs designed to treat cognitive neurological disorders. Umecrine Cognition is based in Solna, Sweden and was founded in 2006. Its last reported valuation was $71.5 million in Jul 2021. It has raised $28.1 million.

Last reported valuation

$71.5M

Oct 2026

Priced at

—

Total raised

$28.1M

Last round

—

How much has Umecrine Cognition raised?

$28.1Macross 0 recorded rounds

Free account

More of Umecrine Cognition with a free account

·Watch Umecrine Cognition: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Umecrine Cognition investors

9 investors are on record for Umecrine Cognition, including Almi Invest, Norrlandsfonden, AB Ility and Fort Knox.

For fundraisers

Raising for a company like Umecrine Cognition?

9 investors have backed Umecrine Cognition.

See all 9 investors →

Frequently asked about Umecrine Cognition

How much has Umecrine Cognition raised?: Umecrine Cognition has raised $28.1M in total across 0 recorded funding rounds.